Irbesartan attenuates production of high-mobility group box 1 in response to lipopolysaccharide via downregulation of interferon-β production
- 1 May 2015
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 26 (1) , 97-102
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic SubjectsDiabetes Care, 2010
- Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetesDiabetologia, 2009
- The cytokine activity of HMGB1Journal of Leukocyte Biology, 2005
- Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Reversing established sepsis with antagonists of endogenous high-mobility group box 1Proceedings of the National Academy of Sciences of the United States of America, 2003
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999
- Flexing DNA: HMG-Box Proteins and Their PartnersThe American Journal of Human Genetics, 1998
- Cytotoxicity of mycotoxins evaluated by the MTT-cell culture assayMycopathologia, 1994
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981